<HashMap><database>biostudies-literature</database><scores/><additional><submitter>de Almeida LGN</submitter><funding>CIHR</funding><pagination>1256</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9027992</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(8)</volume><pubmed_abstract>Platelets may be pivotal mediators of the thrombotic and coagulopathic complications of preeclampsia (PE), linking inflammation and thrombosis with endothelial and vascular dysfunction. Both PE and gestational hypertension (GH) fall within the spectrum of hypertensive complications of pregnancy, with GH being a risk factor for preeclampsia. However, it is unclear what biomarkers distinguish PE from GH. Using a discovery size cohort, we aimed to characterize specific plasma and platelet thrombo-inflammatory drivers indicative of PE and differentiate PE from GH. We performed multiplex immunoassays, platelet and plasma quantitative proteomics and metabolomics of PE patients, comparing with non-pregnant (NP), healthy pregnant controls (PC) and GH participants. The expression pattern of plasma </pubmed_abstract><journal>Cells</journal><pubmed_title>Proteomics and Metabolomics Profiling of Platelets and Plasma Mediators of Thrombo-Inflammation in Gestational Hypertension and Preeclampsia.</pubmed_title><pmcid>PMC9027992</pmcid><funding_grant_id>449589</funding_grant_id><pubmed_authors>Nicholas J</pubmed_authors><pubmed_authors>Dufour A</pubmed_authors><pubmed_authors>Lee A</pubmed_authors><pubmed_authors>Poon MC</pubmed_authors><pubmed_authors>Young D</pubmed_authors><pubmed_authors>Agbani EO</pubmed_authors><pubmed_authors>Chow L</pubmed_authors><pubmed_authors>de Almeida LGN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Proteomics and Metabolomics Profiling of Platelets and Plasma Mediators of Thrombo-Inflammation in Gestational Hypertension and Preeclampsia.</name><description>Platelets may be pivotal mediators of the thrombotic and coagulopathic complications of preeclampsia (PE), linking inflammation and thrombosis with endothelial and vascular dysfunction. Both PE and gestational hypertension (GH) fall within the spectrum of hypertensive complications of pregnancy, with GH being a risk factor for preeclampsia. However, it is unclear what biomarkers distinguish PE from GH. Using a discovery size cohort, we aimed to characterize specific plasma and platelet thrombo-inflammatory drivers indicative of PE and differentiate PE from GH. We performed multiplex immunoassays, platelet and plasma quantitative proteomics and metabolomics of PE patients, comparing with non-pregnant (NP), healthy pregnant controls (PC) and GH participants. The expression pattern of plasma </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-05-18T03:12:24.446Z</modification><creation>2025-04-04T10:01:50.162Z</creation></dates><accession>S-EPMC9027992</accession><cross_references><pubmed>35455936</pubmed><doi>10.3390/cells11081256</doi></cross_references></HashMap>